Sponsored Links
| Study Demonstrates Micromet's Blinatumomab Produces High Single-Agent Activity In Patients With Relapsed Acute Lymphoblastic Leukemia |
 |
 |
 |
| Medical News - Hematology | |||
|
Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy... Read more: Blood / Hematology News From Medical News Today
|